NASDAQ:QTRX

Quanterix Stock Forecast, Price & News

$61.09
-2.52 (-3.96 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$59.23
Now: $61.09
$63.35
50-Day Range
$51.41
MA: $62.67
$82.66
52-Week Range
$20.87
Now: $61.09
$92.57
Volume209,709 shs
Average Volume438,231 shs
Market Capitalization$2.22 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.71
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Quanterix logo

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:QTRX
CUSIPN/A
Phone617-301-9400
Employees314
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$56.73 million
Book Value$4.59 per share

Profitability

Net Income$-40,800,000.00

Miscellaneous

Market Cap$2.22 billion
Next Earnings Date5/4/2021 (Estimated)
OptionableNot Optionable

Headlines

-$0.32 EPS Expected for Quanterix Co. (NASDAQ:QTRX) This Quarter
April 10, 2021 |  americanbankingnews.com
Quanterix (NASDAQ:QTRX) Trading Up 7.2%
April 6, 2021 |  americanbankingnews.com
Quanterix (NASDAQ:QTRX) Shares Gap Up to $54.66
March 31, 2021 |  americanbankingnews.com
Quanterix (NASDAQ:QTRX) Shares Gap Down to $60.33
March 24, 2021 |  americanbankingnews.com
See More Headlines

MarketRank

Overall MarketRank

1.42 out of 5 stars

Medical Sector

630th out of 2,024 stocks

Analytical Instruments Industry

13th out of 29 stocks

Analyst Opinion: 2.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
$61.09
-2.52 (-3.96 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive QTRX News and Ratings via Email

Sign-up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Quanterix (NASDAQ:QTRX) Frequently Asked Questions

Is Quanterix a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Quanterix stock.
View analyst ratings for Quanterix
or view top-rated stocks.

What stocks does MarketBeat like better than Quanterix?

Wall Street analysts have given Quanterix a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Quanterix wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Quanterix's next earnings date?

Quanterix is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for Quanterix
.

How were Quanterix's earnings last quarter?

Quanterix Co. (NASDAQ:QTRX) announced its quarterly earnings data on Monday, March, 1st. The company reported ($0.31) earnings per share for the quarter, beating analysts' consensus estimates of ($0.33) by $0.02. The company had revenue of $26.13 million for the quarter, compared to analysts' expectations of $25.35 million. Quanterix had a negative net margin of 41.69% and a negative trailing twelve-month return on equity of 22.37%.
View Quanterix's earnings history
.

How has Quanterix's stock been impacted by COVID-19 (Coronavirus)?

Quanterix's stock was trading at $18.51 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, QTRX shares have increased by 230.0% and is now trading at $61.09.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for QTRX?

3 equities research analysts have issued 1 year price objectives for Quanterix's stock. Their forecasts range from $40.00 to $90.00. On average, they expect Quanterix's stock price to reach $71.67 in the next twelve months. This suggests a possible upside of 17.3% from the stock's current price.
View analysts' price targets for Quanterix
or view top-rated stocks among Wall Street analysts.

Who are Quanterix's key executives?

Quanterix's management team includes the following people:
  • Mr. E. Kevin Hrusovsky, Chairman, Pres & CEO (Age 59, Pay $1.31M)
  • Dr. David R. Walt, Co-Founder, Chairman of Scientific Advisory Board & Independent Director (Age 68, Pay $41k)
  • Mr. Amol Chaubal, Chief Financial Officer (Age 45, Pay $501.87k)
  • Mr. John J. Fry, Gen. Counsel & Corp. Sec. (Age 60, Pay $465k)
  • Mr. Bruce J. Bal, VP of Operations, Service & Quality (Age 62)
  • Mr. William Geist, Chief Operating Officer
  • Dr. David C. Duffy Ph.D., Sr. VP of R&D and CTO (Age 50)
  • David Panzerella, VP of Sales
  • Dr. Mark T. Roskey, Sr. VP of Commercial & Accelerator (Age 61)
  • Dr. Dawn R. Mattoon Ph.D., Sr. VP of Research Products (Age 48)

What is Kevin Hrusovsky's approval rating as Quanterix's CEO?

15 employees have rated Quanterix CEO Kevin Hrusovsky on Glassdoor.com. Kevin Hrusovsky has an approval rating of 70% among Quanterix's employees.

Who are some of Quanterix's key competitors?

What other stocks do shareholders of Quanterix own?

When did Quanterix IPO?

(QTRX) raised $50 million in an IPO on Thursday, December 7th 2017. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morga and Leerink Partners acted as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

How do I buy shares of Quanterix?

Shares of QTRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quanterix's stock price today?

One share of QTRX stock can currently be purchased for approximately $61.09.

How much money does Quanterix make?

Quanterix has a market capitalization of $2.22 billion and generates $56.73 million in revenue each year. The company earns $-40,800,000.00 in net income (profit) each year or ($1.63) on an earnings per share basis.

How many employees does Quanterix have?

Quanterix employs 314 workers across the globe.

What is Quanterix's official website?

The official website for Quanterix is www.quanterix.com.

Where are Quanterix's headquarters?

Quanterix is headquartered at 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821.

How can I contact Quanterix?

Quanterix's mailing address is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. The company can be reached via phone at 617-301-9400 or via email at [email protected]


This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.